Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SB 01

Next Previous
Drug Profile

SB 01

Alternative Names: BPR 0L075; DBPR104; SB01; SCB 01A

Latest Information Update: 15 Feb 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator National Health Research Institutes
  • Developer SynCore Biotechnology
  • Class Antineoplastics; Indoles; Small molecules
  • Mechanism of Action Angiogenesis inhibitors; Factor XIa inhibitors; Tubulin polymerisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Head and neck cancer
  • Preclinical Thrombosis
  • No development reported Solid tumours

Most Recent Events

  • 06 Dec 2025 Preclinical trials in Thrombosis in Taiwan (Parenteral) prior to December 2025
  • 06 Dec 2025 Pharmacodynamics and adverse event data from the preclinical studies in Thrombosis presented at the 67th American Society of Hematology Annual Meeting and Exposition
  • 06 Dec 2025 SynCore Biotechnology plans pre-IND studies and clinical trial in Thrombosis

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top